Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 13 September 2005. doi:10.1136/hrt.2005.072322
Heart 2006;92:631-634
Copyright © 2006 BMJ Publishing Group Ltd & British Cardiovascular Society

CARDIOVASCULAR MEDICINE

Propafenone added to ibutilide increases conversion rates of persistent atrial fibrillation

P Korantzopoulos1,*, T M Kolettis1, A Papathanasiou1, K K Naka1, P Kolios1, I Leontaridis1, A Draganigos2, C S Katsouras1, J A Goudevenos1

1 Department of Cardiology, University of Ioannina Medical School, Ioannina, Greece
2 Department of Cardiology, General Hospital of Corfu, Corfu Island, Greece

Correspondence to:
Dr Panagiotis Korantzopoulos
Department of Cardiology, University of Ioannina Medical School, 45110 Ioannina, Greece; pkor{at}oneway.gr

Objective: To assess the effectiveness and safety of pharmacological conversion of persistent atrial fibrillation (AF) with a combined propafenone plus ibutilide regimen.

Methods and results: 100 consecutive patients (66 men, mean (SD) age 65 (10) years) with persistent AF (mean (SD) duration 99 (92) days) admitted for elective pharmacological cardioversion were randomly assigned to treatment with either intravenous ibutilide (1 mg plus an additional 1 mg, if required; n = 51) or oral propafenone (600 mg) plus intravenous ibutilide at the same dose (n = 49). Success rates were 41.1% (21 of 51 patients) for ibutilide alone and 71.4% (35 of 49 patients) for propafenone plus ibutilide (p = 0.0044). However, cardioversion occurred earlier in the ibutilide alone group (55 (20) minutes) compared with the combination group (81 (32) minutes, p = 0.0019). A comparable increase in the QTc interval was observed in both groups but one case of sustained torsade de pointes, requiring electrical cardioversion, was observed in the propafenone plus ibutilide group. No other complications were noted during the hospitalisation period.

Conclusion: Concurrent administration of propafenone plus ibutilide for pharmacological cardioversion of persistent AF is safe and more effective than ibutilide alone.

Keywords: atrial fibrillation; pharmacological cardioversion; propafenone; ibutilide; combination treatment


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Soran, H., Younis, N., Currie, P., Silas, J., Jones, I.R., Gill, G. (2008). Influence of diabetes on the maintenance of sinus rhythm after a successful direct current cardioversion in patients with atrial fibrillation. QJM 101: 181-187 [Abstract] [Full Text]  
  • Liu, T., Li, G., Li, L., Korantzopoulos, P. (2007). Association Between C-Reactive Protein and Recurrence of Atrial Fibrillation After Successful Electrical Cardioversion: A Meta-Analysis. J Am Coll Cardiol 49: 1642-1648 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.